The same group transplanted human lung cancer tissue expressing both IL-34 and PD-L1 in immunologically humanized mice to determine the effect of IL-34 neutralization, along with the immune checkpoint blockade, in human tumors. The gene discussed is IL34; the disease is lung cancer.